Lee Chien-Chang, Lu Xiulan, Xiao Zhenghui, Yang Meiyu, Zhu Yimin
*Department of Emergency Medicine, National Taiwan University Hospital Yunlin Branch, Douliou †Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan ‡Department of Critical Care Medicine, Hunan Children's Hospital §Department of Pediatrics, Hunan Provincial People's Hospital, Changsha, Hunan Province, China.
Shock. 2016 Jun;45(6):620-5. doi: 10.1097/SHK.0000000000000545.
Our goal is to determine the prognostic value of serum N-terminal prohormone of brain natriuretic peptide (NT-proBNP), leukocytosis, and hyperglycemia in patients with severe hand, foot, and mouth disease (HFMD).
This is a prospective cohort study conducted from March 2011 through October 2012 at Hunan Children's Hospital.
Hunan Children's Hospital, a large children's teaching hospital with 1,500-beds located in the Changsha region of Hunan Province in China.
295 children who were presented with clinical manifestation of severe HFMD, and required hospitalization.
Standard supportive treatment for HFMD as recommended by the national guidelines.
Admission blood samples were analyzed for NT-proBNP, leukocyte count, and serum glucose. Independent prognostic value of NT-proBNP for predicting mortality was evaluated using the Cox proportional hazard model adjusting for various covariates.
Area under the curve of receiver operating characteristic (AUROC) analysis suggested that a serum concentration of NT-proBNP concentration more than 1,500 pg/mL is an optimal cutoff point. Twenty-four patients (8.1%) had an NT-proBNP more than 1,500 pg/mL, and a 3-day mortality of 46% (11/24). Adjusted for tachycardia, tachypnea, hypertension, hyperglycemia, leukocytosis, and conscious disturbance on presentation, elevated NT-proBNP was associated with a 22.5-fold (95% confidence interval, 3.56-142.66) increased risk of 3-day mortality. We have further improved the specificity and AUROC values by the HFMD laboratory score, which combines NT-proBNP, leukocytosis, and hyperglycemia.
Routine admission surveillance for NT-proBNP is useful for identifying patients with HFMD at risk for mortality. Further studies are needed to determine whether early intervention in patients with highly elevated NT-proBNP can improve outcome.
我们的目标是确定血清脑钠肽前体N端(NT-proBNP)、白细胞增多和高血糖在重症手足口病(HFMD)患者中的预后价值。
这是一项于2011年3月至2012年10月在湖南省儿童医院进行的前瞻性队列研究。
湖南省儿童医院,是位于中国湖南省长沙地区的一家拥有1500张床位的大型儿童教学医院。
295名出现重症手足口病临床表现且需要住院治疗的儿童。
按照国家指南推荐的手足口病标准支持治疗。
采集入院时血样,分析NT-proBNP、白细胞计数和血糖。使用Cox比例风险模型并调整各种协变量,评估NT-proBNP预测死亡率的独立预后价值。
受试者工作特征曲线下面积(AUROC)分析表明,血清NT-proBNP浓度超过1500 pg/mL是最佳截断点。24名患者(8.1%)的NT-proBNP超过1500 pg/mL,3天死亡率为46%(11/24)。在校正了入院时的心动过速、呼吸急促、高血压、高血糖、白细胞增多和意识障碍后,NT-proBNP升高与3天死亡率增加22.5倍(95%置信区间,3.56 - 142.66)相关。我们通过结合NT-proBNP、白细胞增多和高血糖的手足口病实验室评分进一步提高了特异性和AUROC值。
常规入院时监测NT-proBNP有助于识别有死亡风险的手足口病患者。需要进一步研究以确定对NT-proBNP高度升高的患者进行早期干预是否能改善预后。